UK Prospective Diabetes Study Group (1999) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853
Google Scholar
Prospective Diabetes Study Group UK (1995) Overview of 6 years’ therapy of type II diabetes: a progressive disease. UK Prospective Diabetes Study 16. Diabetes 44:1249–1258
Article
Google Scholar
Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794
PubMed
Article
CAS
Google Scholar
Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3–19
PubMed
Article
CAS
Google Scholar
Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110
PubMed
Article
CAS
Google Scholar
Hanley SC, Austin E, Assouline-Thomas B et al (2010) {beta}-Cell mass dynamics and islet cell plasticity in human type 2 diabetes. Endocrinology 151:1462–1472
PubMed
Article
CAS
Google Scholar
Pories WJ, Caro JF, Flickinger EG, Meelheim HD, Swanson MS (1987) The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville Gastric Bypass. Ann Surg 206:316–323
PubMed
Article
CAS
Google Scholar
Rubino F, Forgione A, Cummings DE et al (2006) The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 244:741–749
PubMed
Article
Google Scholar
Kashyap SR, Daud S, Kelly KR et al (2010) Acute effects of gastric bypass vs gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) 34:462–471
Article
CAS
Google Scholar
Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI (2005) Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54:603–608
PubMed
Article
CAS
Google Scholar
Taylor R (2008) Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia 51:1781–1789
PubMed
Article
CAS
Google Scholar
Hother-Nielsen O, Henriksen JE, Holst JJ, Beck-Nielsen H (1996) Effects of insulin on glucose turnover rates in vivo: isotope dilution vs constant specific activity technique. Metabolism 45:82–91
PubMed
Article
CAS
Google Scholar
Ravikumar B, Gerrard J, Dalla Man C et al (2008) Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content. Diabetes 57:2288–2295
PubMed
Article
CAS
Google Scholar
DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223
PubMed
CAS
Google Scholar
Rizza RA, Mandarino LJ, Gerich JE (1981) Dose–response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 240:E630–E639
PubMed
CAS
Google Scholar
Toschi E, Camastra S, Sironi AM et al (2002) Effect of acute hyperglycemia on insulin secretion in humans. Diabetes 51(Suppl 1):S130–S133
PubMed
Article
CAS
Google Scholar
Hovorka R, Soons PA, Young MA (1996) ISEC: a program to calculate insulin secretion. Comput Meth Programs Biomed 50:253–264
Article
CAS
Google Scholar
Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368–377
PubMed
Article
Google Scholar
Glover GH, Schneider E (1991) Three-point Dixon technique for true water/fat decomposition with B0 inhomogeneity correction. Magn Reson Med 18:371–383
PubMed
Article
CAS
Google Scholar
Szczepaniak LS, Nurenberg P, Leonard D et al (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288:E462–E468
PubMed
Article
CAS
Google Scholar
Pfeifer MA, Halter JB, Porte D (1981) Insulin secretion in diabetes mellitus. Am J Med 70:579–588
PubMed
Article
CAS
Google Scholar
Igoillo-Esteve M, Marselli L, Cunha DA et al (2010) Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia 53:1395–1405
PubMed
Article
CAS
Google Scholar
Cnop M (2008) Fatty acids and glucolipotoxicity in the pathogenesis of type 2 diabetes. Biochem Soc Trans 36:348–352
PubMed
Article
CAS
Google Scholar
Noushmehr H, D’Amico E, Farilla L et al (2005) Fatty acid translocase (FAT/CD36) is localized on insulin-containing granules in human pancreatic beta-cells and mediates fatty acid effects on insulin secretion. Diabetes 54:472–481
PubMed
Article
CAS
Google Scholar
Carpentier A, Zinman B, Leung N et al (2003) Free fatty acid-mediated impairment of glucose-stimulated insulin secretion in nondiabetic Oji-Cree individuals from the Sandy Lake community of Ontario, Canada: a population at very high risk for developing type 2 diabetes. Diabetes 52:1485–1495
PubMed
Article
CAS
Google Scholar
Kashyap S, Belfort R, Gastaldelli A et al (2003) A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52:2461–2474
PubMed
Article
CAS
Google Scholar
Tushuizen ME, Bunck MC, Pouwels PJ et al (2007) Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 30:2916–2921
PubMed
Article
CAS
Google Scholar
Saisho Y, Butler AE, Butler PC (2008) Pancreatic fat content and beta-cell function in men with and without type 2 diabetes: response to Tushuizen et al. Diabetes Care 31:e38, author reply e39
PubMed
Article
Google Scholar
Saisho Y, Butler AE, Meier JJ et al (2007) Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat 20:933–942
PubMed
Article
CAS
Google Scholar
Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH (1994) Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte–beta-cell relationships. Proc Natl Acad Sci USA 91:10878–10882
PubMed
Article
CAS
Google Scholar
Lee Y, Lingvay I, Szczepaniak LS, Ravazzola M, Orci L, Unger RH (2010) Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents. Int J Obes (Lond) 34:396–400
Article
CAS
Google Scholar
Morgan NG, Dhayal S, Diakogiannaki E, Welters HJ (2008) The cytoprotective actions of long-chain mono-unsaturated fatty acids in pancreatic beta-cells. Biochem Soc Trans 36:905–908
PubMed
Article
CAS
Google Scholar
Erion DM, Shulman GI (2010) Diacylglycerol-mediated insulin resistance. Nat Med 16:400–402
PubMed
Article
CAS
Google Scholar
Perseghin G, Bonfanti R, Magni S et al (2006) Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am J Physiol Endocrinol Metab 291:E697–E703
PubMed
Article
CAS
Google Scholar
Gastaldelli A, Cusi K, Pettiti M et al (2007) Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 133:496–506
PubMed
Article
CAS
Google Scholar
D’Adamo E, Cali AM, Weiss R et al (2010) Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 33:1817–1822
PubMed
Article
Google Scholar
Tiikkainen M, Bergholm R, Vehkavaara S et al (2003) Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes 52:701–707
PubMed
Article
CAS
Google Scholar
Kirk E, Reeds DN, Finck BN, Mayurranjan SM, Patterson BW, Klein S (2009) Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology 136:1552–1560
PubMed
Article
CAS
Google Scholar
Guidone C, Manco M, Valera-Mora E et al (2006) Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 55:2025–2031
PubMed
Article
CAS
Google Scholar
Morinigo R, Lacy AM, Casamitjana R, Delgado S, Gomis R, Vidal J (2006) GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects. Obes Surg 16:1594–1601
PubMed
Article
Google Scholar
Rodieux F, Giusti V, D’Alessio DA, Suter M, Tappy L (2008) Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity (Silver Spring) 16:298–305
Article
CAS
Google Scholar
Knop FK (2009) Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling? Diabetologia 52:2270–2276
PubMed
Article
CAS
Google Scholar
Rubino F, Gagner M, Gentileschi P et al (2004) The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 240:236–242
PubMed
Article
Google Scholar
Isbell JM, Tamboli RA, Hansen EN et al (2010) The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care 33:1438–1442
PubMed
Article
CAS
Google Scholar
Laferrere B, Teixeira J, McGinty J et al (2008) Effect of weight loss by gastric bypass surgery vs hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 93:2479–2485
PubMed
Article
CAS
Google Scholar
He S, McPhaul C, Li JZ et al (2010) A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 285:6706–6715
PubMed
Article
CAS
Google Scholar